Q BioMed Inc. (QBIO)
OTCMKTS: QBIO · Delayed Price · USD
0.0002
0.00 (0.00%)
Apr 18, 2024, 2:32 PM EDT - Market open

Q BioMed Balance Sheet

Millions USD. Fiscal year is Dec - Nov.
Year 2022202120202019201820172016201520142013
Cash & Equivalents
0.050.340.180.172.680.821.470.130.010.03
Cash & Cash Equivalents
0.050.340.180.172.680.821.470.130.010.03
Cash Growth
-85.47%94.20%2.61%-93.57%225.47%-43.84%1017.68%938.88%-49.40%-
Receivables
0.010.0800000000
Inventory
-00.0200000000
Other Current Assets
0.010.010.050.020.0100000
Total Current Assets
0.070.460.220.192.70.831.470.130.010.03
Long-Term Investments
3.14000000000
Intangible Assets
0.30.350.40.450.500000
Total Long-Term Assets
3.440.350.40.450.500000
Total Assets
3.520.810.620.643.20.831.470.130.010.03
Accounts Payable
2.131.350.720.650.390.460.5000
Deferred Revenue
0000000.12000
Current Debt
4.113.050.093.24002.50.300
Other Current Liabilities
1.891.10.891.340.040.010.170.0900
Total Current Liabilities
8.135.491.75.240.430.473.280.3900
Long-Term Debt
0000.452.8700.23000
Other Long-Term Liabilities
-0000000000
Total Long-Term Liabilities
-0000.452.8700.23000
Total Liabilities
8.135.491.75.693.30.473.510.3900
Total Debt
4.113.050.093.692.8702.730.300
Debt Growth
34.62%3211.86%-97.50%28.45%--821.12%---
Common Stock
0.080.030.020.020.010.010.010.0100
Retained Earnings
-66.1-64.13-55.89-42.39-32.11-22.84-8.3-1.13-0.04-0
Comprehensive Income
0-000000000
Shareholders' Equity
-4.62-4.69-1.08-5.05-0.110.36-2.04-0.260.010.02
Total Liabilities and Equity
3.520.810.620.643.20.831.470.130.010.03
Net Cash / Debt
-4.06-2.710.08-3.52-0.190.82-1.26-0.160.010.03
Net Cash / Debt Growth
---------49.40%-
Net Cash Per Share
-0.09-0.100.00-0.23-0.010.08-0.14-0.020.000.01
Working Capital
-8.06-5.04-1.48-5.052.270.36-1.81-0.260.010.02
Book Value Per Share
-0.10-0.17-0.05-0.34-0.010.03-0.23-0.030.000.01
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.